Global Intracranial Aneurysm Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Surgical Clipping, Endovascular Coiling, Flow Diverters, and Others.

By End Use;

Hospitals, Clinics, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn105987076 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Intracranial Aneurysm Market (USD Million), 2021 - 2031

In the year 2023, the Global Intracranial Aneurysm Market was valued at USD 1,029.69 million. The size of this market is expected to increase to USD 2,276.31 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 12.0%.

The market is driven by a combination of factors, including increasing incidence rates of intracranial aneurysms, rising awareness about preventive healthcare measures, and advancements in diagnostic imaging technologies. With the aging population and lifestyle factors such as hypertension and smoking contributing to the prevalence of intracranial aneurysms, there is a growing demand for innovative diagnostic tools and treatment modalities that can accurately identify and manage these conditions.

Key players in the market are investing heavily in research and development to introduce novel therapies and devices aimed at improving patient outcomes and reducing the risks associated with intracranial aneurysms. From minimally invasive endovascular procedures to advanced surgical techniques, healthcare providers have access to a wide array of treatment options tailored to individual patient needs. Technological advancements such as advanced imaging techniques, computer-aided diagnosis, and the integration of artificial intelligence are reshaping the landscape of intracranial aneurysm diagnosis and treatment planning. These innovations enable healthcare professionals to make more accurate and timely clinical decisions, ultimately improving patient care and prognosis.

The market also presents significant opportunities for collaboration between healthcare providers, medical device manufacturers, and pharmaceutical companies to develop comprehensive treatment algorithms and guidelines that optimize patient outcomes. Furthermore, there is a growing focus on patient-centered care, with initiatives aimed at enhancing patient education, support, and access to resources for better disease management and long-term care.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By End Use
    3. Market Snapshot, By Region
  4. Global Intracranial Aneurysm Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging Population

        2. Technological Advancements

        3. Rising Incidence Rates

      2. Restraints
        1. Treatment Complexity

        2. High Healthcare Costs

        3. Limited Access

      3. Opportunities
        1. Innovative Therapies

        2. Advancements in Imaging

        3. Collaborative Research

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Intracranial Aneurysm Market, By Type, 2021 - 2031 (USD Million)
      1. Surgical Clipping

      2. Endovascular Coiling

      3. Flow Diverters

      4. Others

    2. Global Intracranial Aneurysm Market, By End Use, 2021 - 2031 (USD Million)
      1. Hospitals

      2. Clinics

      3. Others

    3. Global Intracranial Aneurysm Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Stryker Corporation
      2. MicroPort Scientific Corporation.
      3. Johnson & Johnson Services, Inc.
      4. MicroVention Inc.
      5. B. Braun Melsungen AG
      6. Integra LifeSciences
      7. RAUMEDIC AG
      8. Terumo Corporation
      9. Delta Surgical
  7. Analyst Views
  8. Future Outlook of the Market